○Tamami Ikegami¹, Yukio Ago^1,2, Shinji Tsukada¹, Kohei Tanibayashi¹, Naoki OKada¹, Masashi Tachibana^1,2 (1. Grad. Sch. of Pharm. Sci., Osaka Univ., 2. MEIC, Osaka Univ.)

○Kohei Anada¹, Hiroyuki Nakamura¹, Toshihiko Murayama¹ (1. Lab. of Chem. Pharm., Grad. Sch. of Pharm. Sci., Chiba Univ.)

○Eriko Kuroda¹, Kaneyasu Nishimura², Susumu Nakata³, Yuki Toda¹, Eishi Ashihara¹, Kazuyuki Takata² (1. Dept. Clin. Transl. Physical., Kyoto Pharm. Univ., 2. Div. Integ. Pharm. Sci., Kyoto Pharm. Univ., 3. Dept. Clin. Oncol., Kyoto Pharm. Univ.)

○Michiko Yoshii¹, Kyouko Takeno², Matsuo Yuuki², Ozawa Koichiro¹ (1. Grad.Sch.Biomed.Health Sci.,Hiroshima Univ., 2. Sch. Pharm. Sci.,Hiroshima Univ)

○Congyun Jin^1,2, Atsushi Yonezawa^1,2, Hiroki Yoshimatsu^1,2, Satoshi Imai¹, Madoka Koyanagi^1,2, Kaori Yamanishi^1,2, Shunsaku Nakagawa¹, Tomohiro Omura¹, Takayuki Nakagawa¹, Junya Nagai³, Kazuo Matsubara¹ (1. Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Japan, 2. Graduate School of Pharmaceutical Sciences, Kyoto University, Japan, 3. Faculty of Pharmaceutical Sciences, Osaka University of Pharmaceutical Sciences)

○Haruna Ono¹, Tatuya Kinzyou¹, Mifune Masaki¹, Saji Hideo², Masashi Ueda¹ (1. Grad. Sch. Pharm. Sci., Oakyama Univ., 2. Grad. Sch. Pharm. Sci., Kyoto Univ.)